Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria.

Jung-Im ShinDerek M FineYingying SangAditya SurapaneniStephan C DunningLesley A InkerThomas D Nolin Alexander R ChangMorgan E Grams

Published in: Journal of the American Society of Nephrology : JASN (2022)

, 44% were prescribed a rosuvastatin daily dose exceeding the FDA's recommended 10 mg daily dose. Our findings suggest the need for greater care in prescribing and monitoring rosuvastatin, particularly in patients who receive high doses, or who have severe CKD.

Keyphrases

physical activity
healthcare
primary care
chronic kidney disease
palliative care
quality improvement
pain management
adverse drug
affordable care act
drug induced
health insurance